已收盤 09-20 16:00:00 美东时间
-0.110
-2.06%
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-18 19:41
INmune Bio Inc. (NASDAQ:INMB) (the "Company" or "INmune Bio"), a clinical-stage inflammation and immunology company focused on developing treatments that harness a patient's innate immune system to fight disease, today
09-13 20:30
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-22 20:31
INmune Bio Inc : Scotiabank Initiates Coverage With Sector Outperform Rating; T...
08-22 11:28
INmune Bio - Entered Into Amended Sales Agreement Relating to Offer, Sale of Sh...
08-10 04:03
INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.63) by 20.63 percent. This is a 38.89 percent decrease over losses of $(0.36) per share from the
08-02 04:54
INmune Bio Inc. Announces New Phase 1 Study Data Demonstrating Dose-Dependent E...
07-29 21:00
INmune Bio Inc. to Report Second Quarter 2024 Financial Results and Provide a C...
07-25 20:00